Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles
ChemBioChem · 02.05.2023 · 24 (9)
DOI: 10.1002/cbic.202200801 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 30.03.2023. Verfasst von Tianyu Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese…. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Messenger RNA (mRNA) is being used as part of an emerging class of biotherapeutics with great promise for preventing and treating a wide range of diseases, as well as encoding programmable nucleases for genome editing. However, mRNA's low stability and immunogenicity, as well as the impermeability of the cell membrane to mRNA greatly limit mRNA's potential for therapeutic use. Lipid nanoparticles (LNPs) are currently one of the most extensively studied nanocarriers for mRNA delivery and have recently been clinically approved for developing mRNA‐based vaccines to prevent COVID‐19. In this review, we summarize the latest advances in designing ionizable lipids and formulating LNPs for intracellular and tissue‐targeted mRNA delivery. Furthermore, we discuss the progress of intracellular mRNA delivery for spatiotemporally controlled CRISPR/Cas9 genome editing by using LNPs. Finally, we provide a perspective on the future of LNP‐based mRNA delivery for CRISPR/Cas9 genome editing and the treatment of genetic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
- University of Chinese Academy of Sciences, Beijing, 100490, P. R. China.
ORCID-Profile: Ming Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Ma, T., Chen, X., & Wang, M. (2023). Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles. ChemBioChem, 24(9). https://doi.org/10.1002/cbic.202200801
Vancouver
Ma T, Chen X, Wang M. Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles. ChemBioChem. 2023;24(9). doi:10.1002/cbic.202200801
BibTeX
@article{Ma2023,
author = {Ma, Tianyu and Chen, Xianghan and Wang, Ming},
title = {Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles},
journal = {ChemBioChem},
year = {2023},
volume = {24},
number = {9},
doi = {10.1002/cbic.202200801}
}
EUVIMED